Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy.
Jay T. Bishoff
Research Funding - Myriad Genetics
Stephen J. Freedland
Consultant or Advisory Role - Bayer
Honoraria - AstraZeneca
Research Funding - Abbott Laboratories
Leah Gerber
No relevant relationships to disclose
Pierre Tennstedt
No relevant relationships to disclose
William Welbourn
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Julia E. Reid
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Markus Graefen
No relevant relationships to disclose
Zaina Sangale
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Eliso Tikishvili
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jimmy Park
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Adib Younus
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Alexander Gutin
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jerry S. Lanchbury
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Guido Sauter
No relevant relationships to disclose
Michael K. Brawer
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Steven Stone
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Thorsten Schlomm
No relevant relationships to disclose